NasdaqCM:AGENBiotechs
Agenus (AGEN) Q3 Profit Of US$63.9 Million Tests Longstanding Loss-Making Narrative
Agenus (NasdaqCM:AGEN) has swung to a profit in Q3 FY 2025, reporting total revenue of US$30.2 million and EPS of US$2.00, with net income of US$63.9 million for the period. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 to US$26.8 million in Q4 2024 and then to US$30.2 million in Q3 2025, while EPS shifted from a loss of US$2.52 per share in Q2 2024 to a loss of US$2.00 in Q4 2024 and then to a profit of US$2.00 in Q3 2025, indicating a sharp turn in reported...